| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |